Beryl Drugs Schedules Board Meeting to Approve Q2 Results
Beryl Drugs Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Beryl Drugs Schedules Board Meeting to Approve Q2 Results Beryl Drugs Limited has scheduled its Board of Directors meeting for 14th Nov'26 to consider and approve the unaudited financial results and the Limited Review Report for the quarter ended 30th Sep'26. Consequently, the trading window for dealing in the company鈥檚 securities, which has been closed since 1st Jul'26 pursuant to SEBI Insider Trading Regulations, will reopen 48 hours after the conclusion of the board meeting.
Original exchange filing (PDF)
More announcements from Beryl Drugs Ltd
- UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.09.2026 路 14 Nov 2026
- OUTCOME OF BOARD MEETING 路 14 Nov 2026
- NON- APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.09.2026 路 08 Oct 2026
- VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026 路 01 Oct 2026
- PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING 路 29 Sept 2026
- considered and approved the increase in limit of material related party transactions with M/S. AMINOVA INFUSIONS PVT. LTD. 路 29 Sept 2026
- OUTCOME OF 33RD ANNUAL GENERAL MEETING 路 29 Sept 2026
- ANNUAL REPORT 2025-2026 路 04 Sept 2026
